No association between a polymorphism in the steroid metabolism gene CYPI 7 and risk of breast cancer
1998

No Link Between CYP17 Gene and Breast Cancer Risk

Sample size: 1426 publication Evidence: high

Author Information

Author(s): AM Dunning, CS Healey, PDP Pharoah, NA Foster, JM Lipscombe, KL Redman, DF Easton, NE Day, BAJ Ponder

Primary Institution: CRC Human Cancer Genetics Research Group, Addenbrooke's Hospital, Cambridge

Hypothesis

Does the CYP17 gene polymorphism affect breast cancer risk in the English population?

Conclusion

The study found no significant association between the CYP17 gene polymorphism and breast cancer risk in the English population.

Supporting Evidence

  • The study included a large sample size of 1426 participants.
  • No significant differences in allele frequencies were found between cases and controls.
  • The odds ratios for breast cancer risk associated with the C allele were not statistically significant.

Takeaway

The study looked at whether a specific gene change affects breast cancer risk, but it found that it doesn't seem to make a difference.

Methodology

A case-control study was conducted with 835 breast cancer cases and 591 control subjects, assessing the association between CYP17 polymorphism and breast cancer risk.

Limitations

The study population was predominantly white, which may limit the generalizability of the findings.

Participant Demographics

Women under 55 diagnosed with breast cancer in East Anglia, England.

Statistical Information

P-Value

0.35

Confidence Interval

0.89-1.37

Statistical Significance

p=0.35

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication